Sort
21,453 grants matching “tuberculosis”
MYCOBACTERIAL CELL WALL RECOGNITION BY MACROPHAGES
$120,420University Of Washington · K08 · FY2000 · AI
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
$120,406Richard A Oberhelman · Tulane University Of Louisiana · R01 · FY2025 · AI
VACCINE AND TREATMENT EVALUATION UNITS - PHASE I CLINICAL TRIAL TO EVALUATE TB THERAPEUTICS
$120,360Daniel Hoft · Saint Louis University · N01 · FY2018 · AI
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
$120,325Sanjay Rajagopalan · Case Western Reserve University · R35 · FY2023 · ES
DIHYDRONEOPTERIN ALDOLASE, A TUBERCULOSIS DRUG TARGET
$120,296Southern Research Institute · R03 · FY2001 · AI
DIHYDRONEOPTERIN ALDOLASE, A TUBERCULOSIS DRUG TARGET
$120,296Southern Research Institute · R03 · FY2002 · AI
Novel TB Prevention Regimens for HIV-Infected Adults
$120,275Richard E Chaisson · Johns Hopkins University · R01 · FY2006 · AI
Toll-like Receptors and the Innate Immune Response
$120,258University Of Washington · K08 · FY2002 · AI
Toll-like Receptors and the Innate Immune Response
$120,258University Of Washington · K08 · FY2003 · AI
Toll-like Receptors and the Innate Immune Response
$120,258University Of Washington · K08 · FY2001 · AI
LOW RANGE NUCLEIC ACID CONTROLS FOR M. TUBERCULOSIS
$120,229Maine Molecular Quality Controls, Inc. · R43 · FY2003 · AI
Multiplex Microarray for Tuberculosis
$120,209Zuheir L Awdeh · Pulsar Clinical Technologies, Inc. · R43 · FY2008 · AI
SELECTIVE EXPRESSION OF LYMPHOKINES IN T LYMPHOCYTES
$120,177University Of Washington · K08 · FY2000 · AI
TNF and Granuloma Formation in Tuberculosis
$120,148Philana Ling Lin · Children'S Hosp Pittsburgh/Upmc Hlth Sys · K08 · FY2008 · AI
Ethanol-fed, CpG-treated mice: Listeria susceptibility
$120,094University Of Iowa · K01 · FY2004 · AA
BOVINE TUBERCULOSIS (BTB) IS AN IMPORTANT AGRICULTURAL DISEASE FROM BOTH AN ECONOMIC AND A PUBLIC HEALTH PERSPECTIVE. MYCOBACTERIUM BOVIS, THE CAUSE OF BTB HAS A WIDE HOST RANGE INCLUDING CATTLE, WHITE-TAILED DEER (ODOCOILEUS VIRGINIANUS), AND HUMANS, AND CAUSES DECREASED MILK AND MEAT PRODUCTION IN CATTLE. HUMANS CAN BECOME INFECTED BY CONTACT WITH INFECTED ANIMALS OR, MORE COMMONLY THROUGH CONSUMPTION OF UNPASTEURIZED MILK. RISK OF ZOONOTIC BTB INFECTION HAS BEEN GREATLY REDUCED IN DEVELOPED COUNTRIES BY A COMBINATION OF EFFECTIVE TEST AND SLAUGHTER CONTROL PROGRAMS AND MILK PASTEURIZATION; HOWEVER, M. BOVIS IS STILL RESPONSIBLE FOR 1-2% OF HUMAN TUBERCULOSIS CASES IN THE US. DUE TO THE RISK OF ZOONOTIC INFECTION, AND THE PRODUCTION LOSSES CAUSED BY BTB, THE US INSTITUTED A BTB ERADICATION PROGRAM IN 1917. THIS PROGRAM INCLUDES SLAUGHTER SURVEILLANCE, AND A LENGTHY TESTING PROTOCOL FOR INFECTED HERDS ESTIMATED TO COST OVER $1.5 MILLION IN A 1000 COW DAIRY HERD. DESPITE OVER 100 YEARS OF DIRECTED NATIONAL CONTROL, OUTBREAKS STILL OCCUR IN CATTLE EVERY YEAR.THERE ARE TWO EXPLANATIONS FOR THE DIFFICULTY IN ELIMINATING BTB. FIRST, BTB INFECTION IN CATTLE REMAINS SUBCLINICAL, AND POTENTIALLY UNDETECTED FOR MONTHS TO YEARS UNTIL LESIONS BECOME LARGE ENOUGH TO IMPAIR ORGAN FUNCTION. SECOND, THERE ARE MULTIPLE SOURCES OF BTB INFECTION IN CATTLE INCLUDING SPILLOVER FROM WILDLIFE, ANIMAL MOVEMENT, ZOONOTIC TRANSMISSION, AND FOMITE TRANSMISSION. THE ONLY KNOWN WILDLIFE RESERVOIR OF BTB IN THE US IS A POPULATION OF WHITE-TAILED DEER IN MICHIGAN, AND CROSS SPECIES TRANSMISSION REMAINS AN IMPORTANT SOURCE OF CATTLE INFECTION THERE. CATTLE TRADE BETWEEN MEXICO AND THE US IS COMMON AND BTB PREVALENCE IS 14.2% IN SOME REGIONS IN MEXICO. MOVEMENT OF ANIMALS FROM MEXICO TO THE US COULD RESULT IN TRANSMISSION; HOWEVER, ANIMAL MOVEMENT AND WILDLIFE DO NOT ACCOUNT FOR ALL OUTBREAKS IN THE US. REMAINING CASES MAY BE LINKED TO ZOONOTIC TRANSMISSION.BECAUSE OF THE POTENTIAL LAG TIME BETWEEN INFECTION AND DETECTION, AND BECAUSE OF THE MULTIPLE POSSIBLE SOURCES OF INFECTION, IDENTIFYING THE SOURCE OF INFECTION IN A HERD ARE DIFFICULT. ALTHOUGH THOROUGH SAMPLING IS ROUTINE IN TRACEBACK INVESTIGATIONS, ANIMAL MOVEMENT RECORDS ARE OFTEN INCOMPLETE, AND OTHER POTENTIAL SOURCES OF INFECTION, INCLUDING ZOONOTIC TRANSMISSION, ARE DIFFICULT TO CHARACTERIZE. TO MAXIMIZE THE INFORMATION AVAILABLE FROM OUTBREAK INVESTIGATIONS, WHOLE GENOME SEQUENCING (WGS) OF M. BOVIS ISOLATES FROM INFECTED HERDS WAS INCORPORATED INTO THE BTB ERADICATION PROGRAM BY THE NATIONAL VETERINARY SERVICES LABORATORIES IN 2013. WE WILL FILL A CRITICAL GAP IN DETERMINING THE SOURCE OF AN OUTBREAK BY PREDICTING TIME AND LOCATION OF INFECTION. OUR OBJECTIVE IS TO UTILIZE M. BOVIS WGS DATA TO INCREASE EFFICIENCY IN OUTBREAK INVESTIGATIONS BY 1) ESTIMATING TIME SINCE HERD INFECTION AND DRIVERS OF VARIATION IN M. BOVIS EVOLUTIONARY RATE, AND 2) PREDICTING THE GEOGRAPHICAL SOURCE OF OUTBREAKS BY ANALYZING PAN-GENOMIC POPULATION STRUCTURE.
$120,000Cornell University · · FY2020 · National Institute of Food and Agriculture
MECHANISMS OF IMMUNE PROTECTION FROM TB: THE DAR DAR TRIAL
$119,916Timothy P Lahey · Dartmouth College · P20 · FY2009 · RR
What Precursors Become Lung-Resident CD4 Memory that Protect Against Respiratory Infections or Cause Lung Pathology?
$119,890Priyadharshini Devarajan · Univ Of Massachusetts Med Sch Worcester · R21 · FY2024 · AI
Genomic and immunological comparisons of M africanum and M tuberculosis
$119,843Bouke C De Jong · New York University School Of Medicine · K01 · FY2008 · TW
DISSEMINATION OF BIOLOGICAL MS TECHNOLOGY & APPLICATIONS AT SCIENTIFIC MEETINGS
$119,808Alma L Burlingame · University Of California, San Francisco · P41 · FY2011 · RR
Genomic and immunological comparisons of M africanum and M tuberculosis
$119,749Bouke C De Jong · New York University School Of Medicine · K01 · FY2009 · TW
HOST DETERMINANTS OF INFECTIOUSNESS IN TUBERCULOSIS
$119,661Univ Of Med/Dent Of Nj-Nj Medical School · K23 · FY2002 · AI
Amyloid-like Interactions in Fungal Aggregation
$119,591Hunter College · S06 · FY2005 · GM
Studies of the Antibacterial Activity of and Resistance to Molecules Targeting the ClpP Peptidase
$119,551Jason K Sello · Brown University · R01 · FY2019 · AI
Feasibility and acceptability of a mHealth-intervention to find and link TB cases to care
$119,543Violet Chihota · Aurum Institute Npc · R21 · FY2015 · TW